December 4, 2020 NVAC Meeting (Virtual)

December 4, 2020

Agenda

Draft NVAC Agenda: December 4, 2020

Time	Agenda Item
1:00 pm – 1:10 pm	CALL TO ORDER AND RULES OF ENGAGEMENT Ann Aikin, Acting Designated Federal Official
1:10 pm – 1:20 pm	OPENING REMARKS Admiral Brett Giroir, Assistant Secretary for Health
1:20 pm – 1:30 pm	CHAIR’S WELCOME Dr. Robert Hopkins, NVAC Chair
1:30 pm – 2:00 pm	PERSPECTIVE: WHY CHILDREN SHOULD EVENTUALLY RECEIVE VACCINES AGAINST SARS-2 CORONAVIRUS Dr. Stanley Plotkin, University of Pennsylvania (Emeritus)
2:00 pm – 2:45 pm	APPROACHES TO INCLUDE PREGNANT WOMEN IN COVID-19 CLINICAL TRIALS Dr. Sascha Ellington, Centers for Disease Control and Prevention Dr. Ruth Faden, Johns Hopkins University Dr. Jeff Roberts, U.S. Food and Drug Administration Dr. Linda Eckert, University of Washington and Representing American College of Obstetricians and Gynecologists Dr. Dana Meaney-Delman, Centers for Disease Control and Prevention Dr. Titi Oduyebo, Centers for Disease Control and Prevention
2:45 pm – 3:00 pm	BREAK
3:00 pm – 4:00 pm	VACCINE SAFETY SYSTEMS AND COVID-19 Dr. Peter Marks, U.S. Food and Drug Administration Dr. Arnold Monto, University of Michigan and Representing the Vaccines and Related Biological Products Advisory Committee Dr. Tom Shimabukuro, Centers for Disease Control and Prevention Dr. Sonali Kochhar, University of Washington
4:00 pm – 4:15 pm	NO COPAYS: COVERAGE FOR COVID-19 VACCINES Jeff Wu, Centers for Medicare & Medicaid Services
4:15 pm – 4:30 pm	REPORT OVERVIEW Dr. Robert Hopkins, NVAC Chair
4:30 pm – 4:45 pm	PUBLIC COMMENT
4:45 pm – 5:30 pm	COMMITTEE DISCUSSION AND VOTE Dr. Robert Hopkins, NVAC Chair

This meeting was held virtually.

View the Meeting Minutes*

Federal Register Notice

View Videos

View the Meeting Recording - Part 1 (Opening, the perspective presentation by Stanley Plotkin, and the panel on pregnant women)

View the Meeting Recording - Part 2 (The vaccine safety systems panel, the presentation on coverage for COVID-19 vaccines, and the report, overview, discussion and vote)

*People using assistive technology may not be able to fully access information in these files. For assistance, contact the HHS Office of Infectious Disease and HIV/AIDS Policy by emailing Ann.Aikin@hhs.gov.